Purchase Order 36C25621P0088
- Not listed
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. to provide COVID-19 VELA TESTING REAGENTS AND CONSUMABLES. The contract, with a potential value of $184,029.47, has a completion date of June 25, 2021 and was awarded on June 11, 2020. This award, which did not have a set-aside, was made in support of the Coronavirus COVID-19 national interest action. Vela Diagnostics USA Inc. is a for-profit organization...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the VELA DIAGNOSTICS VIROKEY SENTOSA requirement. The award, made on January 13, 2021, is a firm-fixed-price purchase order with a potential value of $436,564.36 and a completion date of December 31, 2021. The contract does not have a set-aside designation. Through this award, Vela Diagnostics...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the provision of laboratory testing equipment. The contract has a total small business set-aside designation and a potential value of $149,000.00. It supports the national interest action code for the Coronavirus COVID-19 response. Through past prime federal contract awards,...
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price contract to Vela Diagnostics USA Inc. for the research and development of a probe-based reverse transcriptase polymerase chain reaction (RT-PCR) test for COVID-19. The contract, which was not set aside, has a potential value of $224,780 and a completion date of October 31, 2020. Vela Diagnostics USA Inc. is a global provider of integrated molecular...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $3,981,350.00 firm fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of COVID-19 reagents. The contract, which has no set-aside designation, is for the delivery of branded COVID-19 diagnostic tests compatible with Cepheid's GeneXpert systems that can simultaneously detect SARS-CoV-2, influenza A, influenza B, and RSV. The tests will be...
- The U.S. Department of Veterans Affairs (VA) has awarded a $691,517.55 firm fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide reagent test kits. The contract, which has a period of performance through September 30, 2025, is not designated as a set-aside. This contract is part of the VA's procurement of Cepheid's molecular diagnostic products, including tests for infectious diseases and genetic conditions, to support its...
- This $241,100.00 firm fixed price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is for the provision of COVID reagents to support the VA's clinical diagnostic programs. No set-aside was used for this award. Cepheid has an existing IDIQ contract with the VA to provide COVID-19 and influenza...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order to Diasorin Molecular LLC, a for-profit manufacturer of medical diagnostics, for the provision of COVID-19 tests. The $173,516.52 firm-fixed price contract does not have a set-aside designation and was issued under an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract by VA's Veterans Integrated Service Network (VISN) 23. Diasorin Molecular, which is a foreign-owned company, has...
- This is a federal contract award to Cepheid, a for-profit manufacturer of diagnostic solutions, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $297,970.00 delivery order is for COVID-19 testing products and services, including reagents, test kits, instruments, and platforms. The contract was awarded under the Multiple Award Schedule (MAS) program without a set-aside. Cepheid, which is owned by the Danaher Corporation, has received other federal contracts and...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide reagents. The $187,061.59 firm fixed price contract does not have a set-aside designation and was awarded on October 1, 2020, with a completion date of September 30, 2021. Cepheid, a subsidiary of the Danaher Corporation, has held multiple federal contracts and grants to supply its diagnostic testing equipment,...
The U.S. Department of Veterans Affairs awarded a firm-fixed-price purchase order to Vela Diagnostics USA Inc. for the delivery of SARS-CoV-2 test reagents. The contract, valued at $86,922.21, has an ultimate completion date of October 8, 2021. Vela Diagnostics USA Inc. is a for-profit organization that has previously provided equipment rental, reagents, consumables, and research and development to support COVID-19 testing, HIV genotyping, and next-generation sequencing systems for various federal agencies, including the Department of Veterans Affairs, the Centers for Disease Control and Prevention, the Defense Health Agency, and the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. This contract award is not associated with a set-aside program and is part of the federal government's response to the Coronavirus COVID-19 national emergency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($205k) | 5/25/22 | |
| Not listed | Not listed | $292.3k | 10/9/20 |